Mode
Text Size
Log in / Sign up
N/A N=112 Randomized Other

Comparison of Senofilcon A Toric Lenses to Balafilcon A Toric Lenses Over Extended Wear Period

Astigmatism

Enrolled (actual)
112
Serious AEs
0.6%
Results posted
Nov 2014
Primary outcome: Primary: Corneal Staining — 0.6; 0.8 units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
senofilcon A toric contact lens (Device); balafilcon A toric contact lens (Device)
Age
Adult · 18+ yrs
Sex
All
Sponsor
Johnson & Johnson Vision Care, Inc.
Primary completion
Jan 2008

Outcome Measures

OutcomeResultp-value
PRIMARY
Corneal Staining
0.6; 0.8
PRIMARY
Limbal Redness
0.7; 0.7
PRIMARY
Bulbar Redness
0.9; 0.8
PRIMARY
Tarsal Roughness
1.1; 1.0

Summary

To evaluate two toric contact lenses on the ocular physiology of existing contact lens wearers when used in an extended wear modality of days/six nights.

Eligibility Criteria

Inclusion Criteria

  • Able to wear study lenses in parameters available
  • Non-presbyopes between the ages of 18-45
  • Understand and sign informed consent
  • Willing to follow the protocol
  • Achieve at least 20/30 (6/9) visual acuity (VA) in right eye (OD) and left eye (OS) with study lenses
  • Myopia -0.75 to -6.25, cylinder -0.75 to -1.50 diopters (D) (axis 90 +/- 15, 180 +/- 15) or -1.75 D (axis 90 +/- 10, 180 +/- 10)
  • Adapted soft contact lens wearer
  • Swims no more than once a week
  • Has a wearable pair of spectacles.

Exclusion Criteria

  • Any ocular or systemic disorder which may contraindicate contact lens wear
  • Any topical ocular medication
  • Aphakic
  • Corneal refractive surgery
  • Corneal distortion from hard CL wear or keratoconus
  • Pregnant or lactating
  • Grade 2 or worse slit lamp signs
  • Infectious disease
  • Previous clinical study within 2 weeks
  • Don't agree to participate
  • Polymethyl methacrylate (PMMA) or rigid gas-permeable (RGP) lens wear in last 8 weeks
  • Previous adverse effects that contraindicate extended lens wear.
  • Self-reported symptoms of itchiness or scratchiness with habitual lenses.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00762502). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search